Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure selections remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our https://financefeeds.com/pepsico-pep-shares-drop-4-5-after-earnings-report/